VX-105: Began Phase II trial

Vertex Pharmaceuticals Inc. (VRTX), Cambridge, Mass. Product: VX-105, reactivates the gene for production of fetal hemoglobin (hemoglobin F) Indication: Beta thalassemia Status: Began Phase II trial u...